Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will eventually develop debilitating pain that impacts daily functioning and diminishes their quality of life. Based on prior studies, including a phase III trial, the superiority of denosumab over zoledronic acid (ZA) in delaying or preventing skeletal-related events (pathological fracture, radiation or surgery to the [...]
Men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) will often have debilitating pain that impacts every aspect of their daily functioning thus significantly diminishing their quality of life (QoL). Finding the best drug or treatment to control the pain will allow men to have a more complete and fulfilling life as well as [...]
Today, Malecare posted our latest teleconference with Dr. Neal Shore, M.D. The conference, which was recorded last week, is about Bone Health and Prostate Cancer. It discusses the importance of maintaining healthy bones and methods to accomplish this task when facing advanced prostate cancer. This teleconference was made possible by the generous support of Bayer. [...]
